22 related articles for article (PubMed ID: 17509745)
1. Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancer.
Mashiko S; Kitatani K; Toyoshima M; Ichimura A; Dan T; Usui T; Ishibashi M; Shigeta S; Nagase S; Miyata T; Yaegashi N
Cancer Biol Ther; 2015; 16(2):253-60. PubMed ID: 25587663
[TBL] [Abstract][Full Text] [Related]
2. Intracellular Expression of PAI-1 Specific Aptamers Alters Breast Cancer Cell Migration, Invasion and Angiogenesis.
Fortenberry YM; Brandal SM; Carpentier G; Hemani M; Pathak AP
PLoS One; 2016; 11(10):e0164288. PubMed ID: 27755560
[TBL] [Abstract][Full Text] [Related]
3. PAI-1, a target gene of miR-143, regulates invasion and metastasis by upregulating MMP-13 expression of human osteosarcoma.
Hirahata M; Osaki M; Kanda Y; Sugimoto Y; Yoshioka Y; Kosaka N; Takeshita F; Fujiwara T; Kawai A; Ito H; Ochiya T; Okada F
Cancer Med; 2016 May; 5(5):892-902. PubMed ID: 26817521
[TBL] [Abstract][Full Text] [Related]
4. Non-viral nanocarriers for siRNA delivery in breast cancer.
Zhang J; Li X; Huang L
J Control Release; 2014 Sep; 190():440-50. PubMed ID: 24874288
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future Prospects.
Schmitt M; Mengele K; Gkazepis A; Napieralski R; Magdolen V; Reuning U; Harbeck N
Breast Care (Basel); 2008; 3(s2):3-10. PubMed ID: 20824007
[No Abstract] [Full Text] [Related]
6. Physico-chemical characteristics of lipoplexes influence cell uptake mechanisms and transfection efficacy.
Resina S; Prevot P; Thierry AR
PLoS One; 2009 Jun; 4(6):e6058. PubMed ID: 19557145
[TBL] [Abstract][Full Text] [Related]
7. Real-time quantification of antibody-short interfering RNA conjugate in serum by antigen capture reverse transcription-polymerase chain reaction.
Tan M; Vernes JM; Chan J; Cuellar TL; Asundi A; Nelson C; Yip V; Shen B; Vandlen R; Siebel C; Meng YG
Anal Biochem; 2012 Nov; 430(2):171-8. PubMed ID: 22929697
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.
Hu PF; Zhu YW; Zhong W; Chen YX; Lin Y; Zhang X; Yin C; Yue HY; Xie WF
J Gastroenterol Hepatol; 2008 Dec; 23(12):1917-25. PubMed ID: 18761555
[TBL] [Abstract][Full Text] [Related]
9. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
[TBL] [Abstract][Full Text] [Related]
10. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
11. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
Guo B; Zhang Y; Luo G; Li L; Zhang J
Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
[TBL] [Abstract][Full Text] [Related]
12. In vitro suppression of urokinase plasminogen activator in breast cancer cells--a comparison of two antisense strategies.
Arens N; Gandhari M; Bleyl U; Hildenbrand R
Int J Oncol; 2005 Jan; 26(1):113-9. PubMed ID: 15586231
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of PAI-1 expression in breast cancer carcinoma cells by siRNA at nanomolar range.
Meryet-Figuières M; Resina S; Lavigne C; Barlovatz-Meimon G; Lebleu B; Thierry AR
Biochimie; 2007 Oct; 89(10):1228-33. PubMed ID: 17509745
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]